<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28970483</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children.</ArticleTitle><Pagination><StartPage>762</StartPage><MedlinePgn>762</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">762</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-017-00736-9</ELocationID><Abstract><AbstractText>Protective antibody levels are critical for protection from severe enterovirus 71 infection. However, little is known about the specificities and functional properties of the enterovirus 71-specific antibodies induced by natural infection in humans. Here we characterize 191 plasmablast-derived monoclonal antibodies from three enterovirus 71-infected children, each of whom shows a distinct serological response. Of the 84 enterovirus 71-specific antibodies, neutralizing antibodies that target the rims and floor of the capsid canyon exhibit broad and potent activities at the nanogram level against viruses isolated in 1998-2016. We also find a subset of infected children whose enterovirus 71-specific antibodies are focused on the 3- and 2-fold plateau epitopes localized at the margin of pentamers, and this type of antibody response is associated with lower serum titers against recently circulating strains. Our data provide new insights into the enterovirus 71-specific antibodies induced by natural infection at the serological and clonal levels.Enterovirus 71 is a leading cause of hand-foot-and-mouth disease and herpangina. Here, the authors characterize a large panel of plasmablast-derived IgG mAbs that target the capsid of EV71 to identify neutralizing antibodies induced by natural infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arthur Huang</LastName><ForeName>Kuan-Ying</ForeName><Initials>KY</Initials><Identifier Source="ORCID">0000-0001-6891-6945</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan. arthur1726@cgmh.org.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mei-Feng</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, 33302, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bone and Joint Research Center, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yhu-Chering</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Shin-Ru</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, 33302, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Cheng-Hsun</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Infectious Disease Research Centre, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jainn-Jim</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jen-Ren</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, 70101, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Kuo-Chien</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Tzou-Yien</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan. pidlin@cgmh.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, 33302, Taiwan. pidlin@cgmh.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="Y">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28970483</ArticleId><ArticleId IdType="pmc">PMC5624920</ArticleId><ArticleId IdType="doi">10.1038/s41467-017-00736-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-017-00736-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lin TY, et al. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 2002;34:S52&#x2013;S57. doi: 10.1086/338819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338819</ArticleId><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanh TH, et al. Enterovirus 71-associated hand, foot, and mouth disease, Southern Vietnam, 2011. Emerg. Infect. Dis. 2012;18:2002&#x2013;2005. doi: 10.3201/eid1812.120929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1812.120929</ArticleId><ArticleId IdType="pmc">PMC3557876</ArticleId><ArticleId IdType="pubmed">23194699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TK, et al. Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. Euro. Surveill. 2014;19:20911. doi: 10.2807/1560-7917.ES2014.19.38.20911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.38.20911</ArticleId><ArticleId IdType="pubmed">25306878</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect. Dis. 2014;14:308&#x2013;318. doi: 10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo ST, et al. Reemergence of enterovirus 71 epidemic in northern Taiwan, 2012. PLoS ONE. 2015;10:e0116322. doi: 10.1371/journal.pone.0116322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0116322</ArticleId><ArticleId IdType="pmc">PMC4361668</ArticleId><ArticleId IdType="pubmed">25774888</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, et al. Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J. Clin. Microbiol. 2009;47:3653&#x2013;3662. doi: 10.1128/JCM.00630-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00630-09</ArticleId><ArticleId IdType="pmc">PMC2772620</ArticleId><ArticleId IdType="pubmed">19776232</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2012;2:199&#x2013;205. doi: 10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee KK, et al. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. J. Virol. 2010;84:3339&#x2013;3350. doi: 10.1128/JVI.01019-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01019-09</ArticleId><ArticleId IdType="pmc">PMC2838098</ArticleId><ArticleId IdType="pubmed">20089660</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP, Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoke-Fun C, AbuBakar S. Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes. BMC Microbiol. 2006;6:74. doi: 10.1186/1471-2180-6-74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-6-74</ArticleId><ArticleId IdType="pmc">PMC1569848</ArticleId><ArticleId IdType="pubmed">16939656</ArticleId></ArticleIdList></Reference><Reference><Citation>Bible JM, et al. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J. Clin. Microbiol. 2008;46:3192&#x2013;3200. doi: 10.1128/JCM.00628-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00628-08</ArticleId><ArticleId IdType="pmc">PMC2566106</ArticleId><ArticleId IdType="pubmed">18650362</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CC, et al. Emergence of enterovirus 71 &#x201c;double-recombinant&#x201d; strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71. Arch. Virol. 2010;155:1413&#x2013;1424. doi: 10.1007/s00705-010-0722-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-010-0722-0</ArticleId><ArticleId IdType="pmc">PMC7087135</ArticleId><ArticleId IdType="pubmed">20549263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002;109:e88. doi: 10.1542/peds.109.6.e88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.6.e88</ArticleId><ArticleId IdType="pubmed">12042582</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsuwanon P, et al. Epidemiology and seroepidemiology of human enterovirus 71 among Thai populations. J. Biomed. Sci. 2014;21:16. doi: 10.1186/1423-0127-21-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-21-16</ArticleId><ArticleId IdType="pmc">PMC3937078</ArticleId><ArticleId IdType="pubmed">24548776</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KY, et al. A potent virus-specific antibody-secreting cell response to acute enterovirus 71 infection in Children. J. Infect. Dis. 2015;212:808&#x2013;817. doi: 10.1093/infdis/jiv094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv094</ArticleId><ArticleId IdType="pubmed">25712974</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang ML, et al. Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development. PLoS Negl. Trop. Dis. 2013;7:e2067. doi: 10.1371/journal.pntd.0002067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002067</ArticleId><ArticleId IdType="pmc">PMC3573098</ArticleId><ArticleId IdType="pubmed">23459633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou AH, et al. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS ONE. 2013;8:e79783. doi: 10.1371/journal.pone.0079783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0079783</ArticleId><ArticleId IdType="pmc">PMC3836818</ArticleId><ArticleId IdType="pubmed">24278177</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden SM, et al. Prediction of protection against Asian Enterovirus 71 outbreak strains by cross-neutralizing capacity of Serum from Dutch donors, The Netherlands. Emerg. Infect. Dis. 2016;22:1562&#x2013;1569. doi: 10.3201/eid2209.151579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2209.151579</ArticleId><ArticleId IdType="pmc">PMC4994357</ArticleId><ArticleId IdType="pubmed">27533024</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KY, et al. Focused antibody response to influenza linked to antigenic drift. J. Clin. Invest. 2015;125:2631&#x2013;2645. doi: 10.1172/JCI81104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81104</ArticleId><ArticleId IdType="pmc">PMC4613558</ArticleId><ArticleId IdType="pubmed">26011643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, et al. Antibody neutralization and escape by HIV-1. Nature. 2003;422:307&#x2013;312. doi: 10.1038/nature01470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature01470</ArticleId><ArticleId IdType="pubmed">12646921</ArticleId></ArticleIdList></Reference><Reference><Citation>Fafi-Kremer S, et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J. Exp. Med. 2010;207:2019&#x2013;2031. doi: 10.1084/jem.20090766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20090766</ArticleId><ArticleId IdType="pmc">PMC2931157</ArticleId><ArticleId IdType="pubmed">20713596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Antigenic analysis of divergent genotypes human Enterovirus 71 viruses by a panel of neutralizing monoclonal antibodies: current genotyping of EV71 does not reflect their antigenicity. Vaccine. 2013;31:425&#x2013;430. doi: 10.1016/j.vaccine.2012.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.10.032</ArticleId><ArticleId IdType="pubmed">23088887</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Enterovirus vaccines for an emerging cause of brain-stem encephalitis. N. Engl. J. Med. 2014;370:792&#x2013;794. doi: 10.1056/NEJMp1400601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1400601</ArticleId><ArticleId IdType="pubmed">24571750</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nat. Struct. Mol. Biol. 2012;19:424&#x2013;429. doi: 10.1038/nsmb.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2255</ArticleId><ArticleId IdType="pmc">PMC3378640</ArticleId><ArticleId IdType="pubmed">22388738</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, et al. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proc. Natl. Acad. Sci. USA. 2013;110:5463&#x2013;5467. doi: 10.1073/pnas.1222379110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222379110</ArticleId><ArticleId IdType="pmc">PMC3619292</ArticleId><ArticleId IdType="pubmed">23509286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HW, et al. Generation of murine monoclonal antibodies which cross-neutralize human enterovirus genogroup B isolates. J. Virol. Methods. 2011;173:189&#x2013;195. doi: 10.1016/j.jviromet.2011.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.02.003</ArticleId><ArticleId IdType="pubmed">21315763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku Z, et al. Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J. Virol. 2015;89:12084&#x2013;12095. doi: 10.1128/JVI.02189-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02189-15</ArticleId><ArticleId IdType="pmc">PMC4645313</ArticleId><ArticleId IdType="pubmed">26401034</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochem. Biophys. Res. Commun. 2009;390:1126&#x2013;1128. doi: 10.1016/j.bbrc.2009.09.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.09.103</ArticleId><ArticleId IdType="pubmed">19799860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim XF, et al. Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection. PLoS ONE. 2012;7:e29751. doi: 10.1371/journal.pone.0029751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029751</ArticleId><ArticleId IdType="pmc">PMC3261156</ArticleId><ArticleId IdType="pubmed">22279543</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, et al. Protection against lethal enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loop. Theranostics. 2014;4:498&#x2013;513. doi: 10.7150/thno.7457.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.7457</ArticleId><ArticleId IdType="pmc">PMC3964443</ArticleId><ArticleId IdType="pubmed">24669278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiener TK, Jia Q, Meng T, Chow VT, Kwang J. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved &#x201c;knob&#x201d; region of VP3 protein. PLoS Negl. Trop. Dis. 2014;8:e2895. doi: 10.1371/journal.pntd.0002895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002895</ArticleId><ArticleId IdType="pmc">PMC4038473</ArticleId><ArticleId IdType="pubmed">24875055</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, et al. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J. Virol. 2013;87:11363&#x2013;11370. doi: 10.1128/JVI.01926-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01926-13</ArticleId><ArticleId IdType="pmc">PMC3807339</ArticleId><ArticleId IdType="pubmed">23946455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pappas L, et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature. 2014;516:418&#x2013;422. doi: 10.1038/nature13764.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13764</ArticleId><ArticleId IdType="pubmed">25296253</ArticleId></ArticleIdList></Reference><Reference><Citation>Weitkamp JH, et al. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific memory B cells expressing the intestinal homing receptor alpha4beta7. J. Immunol. 2005;174:3454&#x2013;3460. doi: 10.4049/jimmunol.174.6.3454.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.6.3454</ArticleId><ArticleId IdType="pubmed">15749880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorny MK, et al. Preferential use of the VH5&#x2013;51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. Mol. Immunol. 2009;46:917&#x2013;926. doi: 10.1016/j.molimm.2008.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2008.09.005</ArticleId><ArticleId IdType="pmc">PMC2693011</ArticleId><ArticleId IdType="pubmed">18952295</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, et al. Mapping enterovirus A71 antigenic determinants from viral evolution. J. Virol. 2015;89:11500&#x2013;11506. doi: 10.1128/JVI.02035-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02035-15</ArticleId><ArticleId IdType="pmc">PMC4645677</ArticleId><ArticleId IdType="pubmed">26339057</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker LM, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science. 2009;326:285&#x2013;289. doi: 10.1126/science.1178746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1178746</ArticleId><ArticleId IdType="pmc">PMC3335270</ArticleId><ArticleId IdType="pubmed">19729618</ArticleId></ArticleIdList></Reference><Reference><Citation>Corti D, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science. 2011;333:850&#x2013;856. doi: 10.1126/science.1205669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205669</ArticleId><ArticleId IdType="pubmed">21798894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilman MS, et al. Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors. Sci. Immunol. 2016;1:eaaj1879. doi: 10.1126/sciimmunol.aaj1879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaj1879</ArticleId><ArticleId IdType="pmc">PMC5244814</ArticleId><ArticleId IdType="pubmed">28111638</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrammert J, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature. 2008;453:667&#x2013;671. doi: 10.1038/nature06890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06890</ArticleId><ArticleId IdType="pmc">PMC2515609</ArticleId><ArticleId IdType="pubmed">18449194</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyamvada L, et al. B cell responses during secondary dengue virus infection are dominated by highly cross-reactive, memory-derived plasmablasts. J. Virol. 2016;90:5574&#x2013;5585. doi: 10.1128/JVI.03203-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03203-15</ArticleId><ArticleId IdType="pmc">PMC4886779</ArticleId><ArticleId IdType="pubmed">27030262</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzofsky JA. T-B reciprocity. An Ia-restricted epitope-specific circuit regulating T cell-B cell interaction and antibody specificity. Surv. Immunol. Res. 1983;2:223&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">6201979</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin AD, Shulman Z, Nussenzweig MC. Clonal selection in the germinal centre by regulated proliferation and hypermutation. Nature. 2014;509:637&#x2013;640. doi: 10.1038/nature13300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13300</ArticleId><ArticleId IdType="pmc">PMC4271732</ArticleId><ArticleId IdType="pubmed">24805232</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauli NT, et al. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J. Exp. Med. 2014;211:2331&#x2013;2339. doi: 10.1084/jem.20141404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20141404</ArticleId><ArticleId IdType="pmc">PMC4235641</ArticleId><ArticleId IdType="pubmed">25348152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndifon W, Wingreen NS, Levin SA. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl Acad. Sci. USA. 2009;106:8701&#x2013;8706. doi: 10.1073/pnas.0903427106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0903427106</ArticleId><ArticleId IdType="pmc">PMC2688967</ArticleId><ArticleId IdType="pubmed">19439657</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, et al. Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies. Immunity. 2013;39:245&#x2013;258. doi: 10.1016/j.immuni.2013.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.04.012</ArticleId><ArticleId IdType="pmc">PMC3985390</ArticleId><ArticleId IdType="pubmed">23911655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gans HA, et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA. 1998;280:527&#x2013;532. doi: 10.1001/jama.280.6.527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.280.6.527</ArticleId><ArticleId IdType="pubmed">9707142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sande CJ, Cane PA, Nokes DJ. The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants. Vaccine. 2014;32:4726&#x2013;4729. doi: 10.1016/j.vaccine.2014.05.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.05.038</ArticleId><ArticleId IdType="pmc">PMC4141889</ArticleId><ArticleId IdType="pubmed">25005882</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc. Biol. Sci. 2015;282:20143085. doi: 10.1098/rspb.2014.3085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rspb.2014.3085</ArticleId><ArticleId IdType="pmc">PMC4707740</ArticleId><ArticleId IdType="pubmed">26702035</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson PC, Andrews SF. Tools to therapeutically harness the human antibody response. Nat. Rev. Immunol. 2012;12:709&#x2013;719. doi: 10.1038/nri3285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3285</ArticleId><ArticleId IdType="pmc">PMC7097371</ArticleId><ArticleId IdType="pubmed">23007571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298:2199&#x2013;2202. doi: 10.1126/science.1076071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1076071</ArticleId><ArticleId IdType="pubmed">12481138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinkernagel RM, Hengartner H. Protective &#x2018;immunity&#x2019; by pre-existent neutralizing antibody titers and preactivated T cells but not by so-called &#x2018;immunological memory&#x2019;. Immunol. Rev. 2006;211:310&#x2013;319. doi: 10.1111/j.0105-2896.2006.00402.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2006.00402.x</ArticleId><ArticleId IdType="pubmed">16824138</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N. Engl. J. Med. 2007;357:1903&#x2013;1915. doi: 10.1056/NEJMoa066092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa066092</ArticleId><ArticleId IdType="pubmed">17989383</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson KJ, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe. 2014;16:105&#x2013;114. doi: 10.1016/j.chom.2014.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.05.013</ArticleId><ArticleId IdType="pmc">PMC4158033</ArticleId><ArticleId IdType="pubmed">24981332</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2016;501:79&#x2013;87. doi: 10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9:e1003511. doi: 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, et al. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 2012;287:6406&#x2013;6420. doi: 10.1074/jbc.M111.301622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J. Virol. 2013;87:3335&#x2013;3347. doi: 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler KL, et al. The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. J. Virol. 2015;89:1900&#x2013;1908. doi: 10.1128/JVI.03098-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03098-14</ArticleId><ArticleId IdType="pmc">PMC4300772</ArticleId><ArticleId IdType="pubmed">25428877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, et al. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell. 2014;5:692&#x2013;703. doi: 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. J. Biol. Chem. 1989;264:14587&#x2013;14590.</Citation><ArticleIdList><ArticleId IdType="pubmed">2670920</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol. J. 2009;6:141. doi: 10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Plevka P, et al. Neutralizing antibodies can initiate genome release from human enterovirus 71. Proc. Natl Acad. Sci. USA. 2014;111:2134&#x2013;2139. doi: 10.1073/pnas.1320624111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1320624111</ArticleId><ArticleId IdType="pmc">PMC3926013</ArticleId><ArticleId IdType="pubmed">24469789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, et al. Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Proc. Natl Acad. Sci. USA. 2017;114:770&#x2013;775. doi: 10.1073/pnas.1616502114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616502114</ArticleId><ArticleId IdType="pmc">PMC5278457</ArticleId><ArticleId IdType="pubmed">28074040</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-linked Agammaglobulinemia: update on epidemiology and therapy. J. Allergy Clin. Immunol. Pract. 2016;4:1059&#x2013;1065. doi: 10.1016/j.jaip.2015.12.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2015.12.015</ArticleId><ArticleId IdType="pubmed">26883540</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibriansah G, et al. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol. Med. 2014;6:358&#x2013;371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3958310</ArticleId><ArticleId IdType="pubmed">24421336</ArticleId></ArticleIdList></Reference><Reference><Citation>Shingler KL, et al. The enterovirus 71 A-particle forms a gateway to allow genome release: a cryoEM study of picornavirus uncoating. PLoS Pathog. 2013;9:e1003240. doi: 10.1371/journal.ppat.1003240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003240</ArticleId><ArticleId IdType="pmc">PMC3605244</ArticleId><ArticleId IdType="pubmed">23555253</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>